Skip to Main Content


  • Developmental toxicology encompasses the study of pharmacokinetics, mechanisms, pathogenesis, and outcome following exposure to agents or conditions leading to abnormal development.
  • Developmental toxicology includes teratology, or the study of structural birth defects.
  • Gametogenesis is the process of forming the haploid germ cells: the egg and the sperm.
  • Organogenesis is the period during which most bodily structures are established. This period of heightened susceptibility to malformations extends from the third to the eighth week of gestation in humans.


Successful pregnancy outcome in the general population occurs at a surprisingly low frequency. Estimates of adverse outcomes include postimplantation pregnancy loss, 31 percent; major birth defects, 2 to 3 percent at birth and increasing to 6 to 7 percent at 1 year as more manifestations are diagnosed; minor birth defects, 14 percent; low birth weight, 7 percent; infant mortality (prior to 1 year of age), 1.4 percent; and abnormal neurologic function, 16 to 17 percent. Thus, less than half of all human conceptions result in the birth of a completely normal, healthy infant. Many hundreds of chemicals are teratogens; most of them produce birth defects by an unknown mechanism. However, Table 10–1 lists chemicals, chemical classes, or conditions known to alter prenatal development in humans.

Table Graphic Jump Location
Table 10–1 Human developmental toxicants.



In 1960, a large increase in newborns with rare limb malformations of amelia (absence of the limbs) or various degrees of phocomelia (reduction of the long bones of the limbs) was recorded in West Germany. Congenital heart disease; ocular, intestinal, and renal anomalies; and malformations of the external and inner ears were also involved. Thalidomide, identified as the causative agent, was used throughout much of the world as a sleep aid and to ameliorate nausea and vomiting in pregnancy. It had no apparent toxicity or addictive properties in adult humans or animals at therapeutic exposure levels.


As a result of this catastrophe, regulatory agencies developed requirements for evaluating the effects of drugs on pregnancy outcomes.




Diethylstilbestrol (DES) is a synthetic nonsteroidal estrogen ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessPharmacy Full Site: One-Year Subscription

Connect to the full suite of AccessPharmacy content and resources including 30+ textbooks such as Pharmacotherapy: A Pathophysiologic Approach and Goodman & Gilman's The Pharmacological Basis of Therapeutics, high-quality videos, images, and animations, interactive board review, drug and herb/supplements databases, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessPharmacy

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.